一品红：关于全资子公司获得艾司奥美拉唑镁肠溶干混悬剂注册证书的公告

Core Points - The company Yipinhong announced that its wholly-owned subsidiary, Guangzhou Yipinhong Pharmaceutical Co., Ltd., has received the drug registration certificate for Esomeprazole Magnesium Enteric-coated Suspension from the National Medical Products Administration [2] Company Summary - Yipinhong's subsidiary has successfully obtained regulatory approval for a new drug, which may enhance its product portfolio and market presence [2] - The approval of Esomeprazole Magnesium Enteric-coated Suspension indicates the company's commitment to expanding its offerings in the pharmaceutical sector [2] Industry Summary - The approval from the National Medical Products Administration reflects the regulatory environment's support for new drug development in the pharmaceutical industry [2] - This development may signal potential growth opportunities within the gastrointestinal treatment market, as Esomeprazole is commonly used for acid-related disorders [2]